A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia
Clinical trial NCT07423104 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07423104
- Sponsor
- University of Rochester
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-15
- Primary completion
- 2029-02-01
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.